What are the recommended treatments for acute hiccups, including first‑line and second‑line pharmacologic options?

Treatment for Hiccups

For acute hiccups, start with simple physical maneuvers (pharyngeal stimulation, breath-holding techniques); if persistent beyond 48 hours, initiate pharmacotherapy with chlorpromazine (25-50 mg orally) or metoclopramide (10 mg orally/IV every 6-8 hours) as first-line agents, with baclofen (5-10 mg three times daily) and gabapentin as alternative first-line options that have fewer side effects for long-term use.

Acute Hiccups (< 48 hours)

Most acute hiccups are benign, self-limited, and resolve spontaneously within minutes 1. The most common identifiable cause is gastric overdistension, followed by gastroesophageal reflux 1.

Non-Pharmacological Interventions

Physical maneuvers should be attempted first as they are simple, safe, and often effective 2, 3:

• Pharyngeal/uvular stimulation (drinking cold water, swallowing granulated sugar)
• Respiratory maneuvers (breath-holding, breathing into a paper bag, Valsalva maneuver)
• Nasopharyngeal stimulation (gentle catheter insertion)

A recent randomized controlled trial demonstrated that patient-directed behavioral-physical interventions significantly shortened median hiccup remission time to 0.17 hours compared to 3.00 hours in controls (P < 0.01) 4.

When to Consider Pharmacotherapy

Medical intervention is rarely needed for acute hiccups but should be considered when hiccups are bothersome or interfere with daily activities 1. If hiccups persist beyond 48 hours, they are classified as persistent and warrant pharmacological treatment 3.

Persistent and Intractable Hiccups (≥ 48 hours)

First-Line Pharmacological Options

The evidence base for hiccup treatment is limited, with no adequately powered randomized controlled trials 3. However, systematic review and clinical experience support the following:

Preferred First-Line Agents (based on efficacy and safety profile):

1. Baclofen: 5-10 mg orally three times daily

   • Supported by small randomized placebo-controlled trials 3
   • Safer for long-term use compared to neuroleptics 3
   • Effective for chronic/intractable hiccups 5

2. Gabapentin: Starting dose varies (typically 300-900 mg/day in divided doses)

   • Less likely to cause side effects during long-term therapy 3
   • Supported by observational data 3

3. Metoclopramide: 10-20 mg orally/IV every 4-6 hours 6

   • Supported by small randomized placebo-controlled trial 3
   • Particularly useful when gastroesophageal reflux is suspected 2, 7

Alternative First-Line Agent:

1. Chlorpromazine: 25-50 mg orally or 12.5-25 mg IV/IM
   • Historically the most widely used agent 2, 7
   • Supported by observational data 3
   • Caution: Higher risk of side effects (sedation, orthostatic hypotension, extrapyramidal symptoms, QTc prolongation) 8
   • Complete resolution reported with 10-25 mg doses 9

Second-Line Options

Atypical Antipsychotics (when first-line agents fail):

• Olanzapine: 2.5-10 mg orally daily 6, 9

  • Complete resolution reported in multiple case series 9
  • Effective in cancer patients 5
  • May cause drowsiness, orthostatic hypotension 10

• Haloperidol: 0.5-2 mg orally/IV every 4-6 hours 6

  • Complete resolution with 1-2 mg doses 9
  • Risk of extrapyramidal side effects 10

Underlying Cause-Directed Therapy

Always attempt to identify and treat the underlying cause 3:

• Gastroesophageal reflux/gastritis: Proton pump inhibitors (pantoprazole) are commonly used 11

  • Upper GI investigations (endoscopy, pH monitoring) should be included systematically in chronic hiccup evaluation 7
  • A recent case series showed efficacy with combined pantoprazole and pheniramine (H1 antihistamine) 11

• Steroid-induced hiccups (in cancer patients): Steroid rotation is most beneficial

  • Replace dexamethasone with methylprednisolone or omit dexamethasone entirely 5
  • This was the most effective intervention in cancer patients receiving chemotherapy 5

Treatment Algorithm

1. Acute hiccups (< 48 hours): Physical maneuvers → observe
2. Persistent hiccups (48 hours - 2 months):
   • Trial of PPI if reflux suspected
   • Initiate baclofen OR gabapentin (preferred for safety)
   • Alternative: metoclopramide or chlorpromazine
3. Intractable hiccups (> 2 months):
   • Continue first-line agent or switch if ineffective
   • Add second-line agent (olanzapine, haloperidol)
   • Consider non-pharmacological interventions (acupuncture 5, nerve blockade 12)

Critical Caveats

• Persistent/intractable hiccups can indicate serious underlying pathology (myocardial infarction, brain tumor, renal failure) 7. Detailed history and physical examination are essential to guide diagnostic workup.

• Chlorpromazine carries significant side effect risks including QTc prolongation, especially when combined with other QT-prolonging medications 8. ECG monitoring may be warranted.

• In cancer patients receiving chemotherapy, consider steroid rotation first before adding other agents 5.

• Most treatment recommendations are based on case reports and observational data rather than high-quality randomized trials 1, 3. Treatment often requires trial-and-error approach.

• Combination therapy may be necessary for refractory cases, but increases risk of drug interactions and side effects.